Predicting virologic failure in an HIV clinic

Clinical Infectious Diseases

Volumn 50, Issue 5, 2010, Pages 779-786

  Robbins, Gregory K ^a,b,c,d   Johnson, Kristin L ^b,c   Chang, Yuchiao ^a,c,d   Jackson, Katherine E ^b   Sax, Paul E ^b,c,d   Meigs, James B ^a,d   Freedberg, Kenneth A ^a,b,c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ALCOHOL ABUSE; ARTICLE; CD4 LYMPHOCYTE COUNT; DRUG ABUSE; ELECTRONIC MEDICAL RECORD; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT FAILURE;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BOSTON; DATA COLLECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASSACHUSETTS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; PROGNOSIS; RISK FACTORS; TREATMENT FAILURE; VIRAL LOAD;

EID: 76749144117     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/650537     Document Type: Article

References (40)

1. 1. Porter K, Babiker A, Bhaskaran K, et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 2003;362:1267-1274. (Pubitemid 37324254)
2. Palella FJ, Delaney K, Moorman A, et al; HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-860.
3. Robbins GK, De Gruttola V, Shafer RW, et al. Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med 2003;349:2293-2303.
4. Gulick RM, Ribaudo HJ, Shikuma CM, et al. Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. N Engl J Med 2004;350:1850-1861.
5. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999;131:81-87.
6. 6. Mocroft A, Ruiz L, Reiss P, et al. Virological rebound after suppression on highly active antiretroviral therapy. AIDS 2003; 17:1741-1751. (Pubitemid 37000092)
7. 7. Robbins GK, Daniels B, Zheng H, Chueh H, Meigs JB, Freedberg KA. Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr 2007;44:30-37. (Pubitemid 46052217)
8. 8. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847. (Pubitemid 28213628)
9. Fortescue EB, Bates DW, Chertow GM. Predicting acute renal failure after coronary bypass surgery: cross-validation of two risk-stratification algorithms. Kidney Int 2000; 57:2594-2602.
10. Walter LC, Brand RJ, Counsell SR, et al. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA 2001;285:2987-2994.
11. 11. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003;290:2581-2587. (Pubitemid 37443288)
12. Leung GM, Rainer TH, Lau FL, et al. A clinical prediction rule for diagnosing severe acute respiratory syndrome in the emergency department. Ann Intern Med 2004; 141:333-342.
13. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-954.
14. 14. Egger M, May M, Chêne G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002;360:119-129. (Pubitemid 34786200)
15. 15. May M, Porter K, Sterne JA, Royston P, Egger M. Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data. J Clin Epidemiol 2005; 58: 1033-1041. (Pubitemid 41316446)
16. 16. Mocroft A, Ledergerber B, Zilmer K, et al. Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score. AIDS 2007;21:1867-1875. (Pubitemid 47329763)
17. 17. May M, Sterne JA, Sabin C, et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS 2007;21:1185-1197. (Pubitemid 46763289)
18. Johannessen A, Naman E, Ngowi BJ, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis 2008; 8:52.
19. 19. Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Initial plasma HIV-I RNA levels and progression to AIDS in women and men. N Engl J Med 2001;344:720-725. (Pubitemid 32204989)
20. Mugavero MJ, Lin HY, Allison JJ, et al. Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr 2009;50:100-108.
21. 21. Watts DH, Lambert J, Stiehm ER, et al. Progression of HIV disease among women following delivery. J Acquir Immune Defic Syndr 2003; 33:585-593. (Pubitemid 36980598)
22. 22. Conigliaro J, Gordon AJ, McGinnis KA, Rabeneck L, Justice AC; Veterans Aging Cohort 3-Site S. How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr 2003;33:521-525. (Pubitemid 36886082)
23. 23. Ironson G, O'Cleirigh C, Fletcher MA, et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med 2005;67:1013-1021. (Pubitemid 43740117)
24. Bardeguez AD, Lindsey JC, Shannon M, et al. Adherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune Defic Syndr 2008; 48:408-417.
25. Linder JA, Schnipper JL, Tsurikova R, Melnikas AJ, Volk LA, Middleton B. Barriers to electronic health record use during patient visits. AMIA Annu Symp Proc 2006:499-503.
26. 26. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30. (Pubitemid 30432540)
27. Dawson DA, Grant BF, Li TK. Quantifying the risks associated with exceeding recommended drinking limits. Alcohol Clin Exp Res 2005; 29:902-908.
28. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 1997; 277: 488-494
29. Xiong C, van Belle G, Miller JP, Morris JC. Measuring and estimating diagnostic accuracy when there are three ordinal diagnostic groups. Stat Med 2006;25:1251-1273.
30. Yang Y, Jin Z. Combining dependent tests to compare the diagnostic accuracies-a non-parametric approach. Stat Med 2006; 25:1239-1250.
31. 31. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180-187. (Pubitemid 32640849)
32. 32. Bandos AI, Rockette HE, Gur D. Incorporating utility-weights when comparing two diagnostic systems: a preliminary assessment. Acad Radiol 2005;12:1293-1300. (Pubitemid 41354255)
33. Liao L, Mark DB. Clinical prediction models: are we building better mousetraps? J Am Coll Cardiol 2003;42:851-853.
34. 34. Howard AA, Arnsten JH, Lo Y, et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 2002;16:2175-2182. (Pubitemid 35387272)
35. 35. Rastegar DA, Fingerhood MI, Jasinski DR. Highly active antiretroviral therapy outcomes in a primary care clinic. AIDS Care 2003; 15:231-237. (Pubitemid 36470007)
36. 36. Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis 2007;44:1493-1499. (Pubitemid 46801595)
37. 37. Hartzell JD, Spooner K, Howard R, Wegner S, Wortmann G. Race and mental health diagnosis are risk factors for highly active antiretroviral therapy failure in a military cohort despite equal access to care. J Acquir Immune Defic Syndr 2007;44:411-416. (Pubitemid 46555375)
38. Wilkin TJ, Taylor B, Olender S, Hammer SM. Advances in antiretroviral therapy. Top HIV Med 2009; 17:68-88.
39. 39. Janssen KJ, Moons KG, Kalkman CJ, Grobbee DE, Vergouwe Y. Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol 2008;61:76-86. (Pubitemid 350236700)
40. 40. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004; 159:882-890. (Pubitemid 38657490)